Citurgia Biochemicals Ltd
₹ 109
-0.96%
24 Aug
4:01 p.m.
About
Incorporated in 1969, Citurgia Biochemicals
Ltd deals in the manufacturing and trading
of citric acid.[1]
Key Points
- Market Cap ₹ 1,435 Cr.
- Current Price ₹ 109
- High / Low ₹ 212 / 47.4
- Stock P/E
- Book Value ₹ -0.59
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 2.00
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.18 | 0.16 | 0.10 | 0.18 | 0.24 | 0.12 | 0.37 | 0.18 | 0.21 | 0.25 | 0.20 | 0.52 | 0.51 | |
| Operating Profit | -0.18 | -0.16 | -0.10 | -0.18 | -0.24 | -0.12 | -0.37 | -0.18 | -0.21 | -0.25 | -0.20 | -0.52 | -0.51 |
| OPM % | |||||||||||||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.58 | 0.50 | 0.43 | 0.37 | 0.32 | 0.28 | 0.24 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 |
| Profit before tax | -0.76 | -0.66 | -0.53 | -0.55 | -0.56 | -0.40 | -0.61 | -0.41 | -0.44 | -0.48 | -0.43 | -0.75 | -0.74 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| -0.76 | -0.66 | -0.54 | -0.55 | -0.56 | -0.40 | -0.61 | -0.40 | -0.44 | -0.48 | -0.42 | -0.74 | -0.74 | |
| EPS in Rs | -0.06 | -0.05 | -0.04 | -0.04 | -0.04 | -0.03 | -0.05 | -0.03 | -0.03 | -0.04 | -0.03 | -0.06 | -0.06 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -5% |
| 3 Years: | -32% |
| TTM: | -68% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 | 26.42 |
| Reserves | -28.35 | -29.01 | -29.55 | -30.10 | -30.66 | -31.06 | -31.67 | -32.08 | -32.51 | -32.99 | -33.41 | -34.15 |
| 4.49 | 4.50 | 5.15 | 6.45 | 6.48 | 6.48 | 6.49 | 6.49 | 6.55 | 6.77 | 6.83 | 6.89 | |
| 8.59 | 9.67 | 9.93 | 10.05 | 10.13 | 10.13 | 10.36 | 10.60 | 10.73 | 10.84 | 10.92 | 11.31 | |
| Total Liabilities | 11.15 | 11.58 | 11.95 | 12.82 | 12.37 | 11.97 | 11.60 | 11.43 | 11.19 | 11.04 | 10.76 | 10.47 |
| 3.66 | 3.16 | 2.73 | 2.36 | 2.04 | 1.76 | 1.52 | 1.30 | 1.07 | 0.85 | 0.62 | 0.40 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 7.49 | 8.42 | 9.22 | 10.46 | 10.33 | 10.21 | 10.08 | 10.13 | 10.12 | 10.19 | 10.14 | 10.07 | |
| Total Assets | 11.15 | 11.58 | 11.95 | 12.82 | 12.37 | 11.97 | 11.60 | 11.43 | 11.19 | 11.04 | 10.76 | 10.47 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.03 | -0.08 | -0.51 | -1.32 | -0.19 | -0.11 | -0.15 | -0.03 | -0.07 | -0.14 | -0.12 | -0.13 | |
| 0.00 | 0.00 | 0.13 | -0.07 | 0.02 | 0.06 | 0.15 | 0.01 | 0.04 | -0.05 | 0.07 | 0.08 | |
| 0.00 | 0.00 | 0.65 | 1.30 | 0.03 | 0.00 | 0.01 | 0.00 | 0.06 | 0.22 | 0.06 | 0.06 | |
| Net Cash Flow | -0.03 | -0.08 | 0.27 | -0.09 | -0.15 | -0.06 | 0.01 | -0.01 | 0.02 | 0.03 | 0.01 | 0.01 |
| Free Cash Flow | -0.03 | -0.08 | -0.51 | -1.32 | -0.19 | -0.11 | -0.15 | -0.03 | -0.07 | -0.14 | -0.12 | -0.13 |
| CFO/OP | 17% | 50% | 510% | 733% | 79% | 92% | 41% | 17% | 33% | 56% | 60% | 25% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | ||||||||||||
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | ||||||||||||
| Working Capital Days | ||||||||||||
| ROCE % | -25.94% | -29.53% | -26.97% | -22.96% | -22.36% | -19.61% | -39.61% | -39.61% | -68.22% | -145.45% | -2,150.00% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Number of Board Meetings count |
|
|||||
| Number of Permanent Employees count |
||||||
| Number of Shareholders count |
||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Results-Delay in Financial Results
- Unaudited Q1 FY2027 results approved; loss of Rs 8.20 lakh for quarter ended 30 June 2026.
-
Board Meeting Intimation for Consider And Approve Unaudited Financial Results (Standalone) For The Quarter Ended June 30, 2026.
- Board meeting on 12 August 2026 to approve Q1 FY2026-27 unaudited standalone results.
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
- Company Secretary and Compliance Officer Yatendra Kumar resigned effective 24 July 2026.
-
Closure of Trading Window
- Trading window closed from 1 July 2026 for Q1 FY2026-27 unaudited results.
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
-
Annual Report 2010
from bse
Business Overview:[1]
CBCL manufactures, processes, and trades citric acid, calcium carbonate, and plasticizers. Citric acid is used in foods, soft drinks, confectionery, pharmaceuticals, and industrial chemicals to provide stable pH conditions for polyester, nylon, acrylic print curing, and cotton-resist printing.